ObsEva is formerly owned by Sofinnova Partners, through Sofinnova Capital VIII, since 2015.

When did Sofinnova Partners acquire ObsEva?

Sofinnova Partners acquired ObsEva in 2015 and exited after 2 years.

Has ObsEva been sold?

Yes. ObsEva was exited in 2017 via IPO.

Home/Companies/Biotech/ObsEva

ObsEva

Biotech·

Switzerland·Exited 2017·Held 2yr

ObsEva is a healthcare / biotech company, headquartered in Switzerland.

Entry

2015

Hold

2yr

Exit

2017

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQSwitzerland

SectorHealthcare / Biotech

Women's reproductive health biotech. IPO on Nasdaq in 2017 IPO Jan 2017 NASDAQ (OBSV).

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Sofinnova Capital VIII

Other portfolio companies in the same fund.

Corvidia Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings